TruSculpt iD & Medication Considerations
At Glow by Elena Reitman MD, TruSculpt iD treatment planning accounts for more than body shape—it considers physiology. Patients often ask whether medications that affect microcirculation, such as vasodilators or beta blockers, can influence how treated fat responds or clears after TruSculpt iD.
Led by Dr. Elena Reitman, our team evaluates circulation, tissue perfusion, and metabolic factors during consultation. TruSculpt iD induces controlled heating of subcutaneous fat to trigger apoptosis, after which the body gradually clears fat cells through normal metabolic and lymphatic pathways. Medications that alter blood flow do not prevent this process, but they may influence timing and local tissue response.
In patients with altered microcirculation, treatment parameters, applicator placement, and post-treatment guidance are adjusted to support consistent heat distribution and optimal recovery. Expectations are set thoughtfully, with emphasis on gradual, natural fat reduction rather than rushed outcomes.
Patients in Cresskill and throughout New Jersey choose Glow because physician oversight ensures treatments are aligned with the whole patient—not just the treatment area. If you’re considering TruSculpt iD and take medications that affect circulation, learn how individualized planning protects both safety and results. Click to learn more and schedule your consultation.
from GMB Posts For Location "Glow by Elena Reitman MD" https://ift.tt/iKJ5a7y
No comments:
Post a Comment